William D. Erwin
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications, Lymphoma Diagnosis and Treatment, Advanced Radiotherapy Techniques, Radiation Dose and Imaging
Most-Cited Works
- → Yttrium-90 Microsphere Therapy for Hepatic Malignancy: Devices, Indications, Technical Considerations, and Potential Complications(2005)320 cited
- → Physics in Nuclear Medicine(2013)260 cited
- → Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma(2000)234 cited
- Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.(2003)
- → Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma(2001)183 cited
- The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.(2005)
- → Yttrium-90 Ibritumomab Tiuxetan Doses Calculated to Deliver up to 15 Gy to Critical Organs May Be Safely Combined With High-Dose BEAM and Autologous Transplantation in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma